Novartis Projects Faster Growth Through 2030 After Raising Drug Forecasts

benzinga.com/markets/earnings/25/11/48983890/novartis-projects-faster-growth-through-2030-after-raising-drug-forecasts

Novartis AG (NYSE:NVS) projects a stronger growth trajectory through 2030, lifting expectations for several key medicines and outlining a pipeline strategy it believes will sustain momentum well into the next decade.
• NVS is having a challenging session. See the full story here.
The…

This story appeared on benzinga.com, 2025-11-20 17:43:29.
The Entire Business World on a Single Page. Free to Use →